Literature DB >> 25556447

Demographic survey of four thousand patients with 10 common cancers in North Eastern Iran over the past three decades.

Zahra Nikfarjam1, Toktam Massoudi, Maryam Salehi, Mahta Salehi, Fahimeh Khoshroo.   

Abstract

BACKGROUND: Cancer is a major cause of mortality in developing countries and correct and valid information about the epidemiology of this disease is the first step in the planning of health care in each region. The aim of this study was to determine the relative frequency, mean age and sex ratio of the most 10 common non-skin cancers in the world and Iran, among patients referred to an oncology clinic.
MATERIALS AND METHODS: This descriptive study was conducted in Mashhad, north east of Iran. The data obtained from the records of patients referred to the private oncology center between the years of 1985-2012." According to the latest report of GLOBOCAN study commonest malignancies included were lung, breast, colorectal, prostate, stomach, liver, cervix, esophageal, bladder cancers and Non-Hodgkin lymphoma.
RESULTS: A total of 4,606 cases were analyzed. The mean age was 55.5±13.8years (male: 59.5±13.9, female: 52.6±12.9). Overall, breast cancer (1,264 cases, relative frequency of 27.4%) was the most prevalent cancer; however the mean ages of diagnosis were not significantly different between 5-year time period divisions (p=0.290). The most common cancer in men was esophageal cancer (26.3%).The lowest mean age was related to women diagnosed with breast cancer (48.5±11.8) and men with non-Hodgkins lymphoma (48.4±17.8). There were statistically significant differences between the mean age of men and women with gastric (p=0.003) and esophageal cancers (p<0.001). Male to female sex ratios in our study for bladder, lung and stomach cancers were 6.57, 2.60 and 2.50 respectively.
CONCLUSIONS: The results showed that breast cancer tends to be found in younger female patients and bladder cancer appears more often in men. Screening in target population in addition to early diagnosis may reduce death and disability.

Entities:  

Mesh:

Year:  2014        PMID: 25556447     DOI: 10.7314/apjcp.2014.15.23.10193

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  The incidence and mortality of esophageal cancer and their relationship to development in Asia.

Authors:  Reza Pakzad; Abdollah Mohammadian-Hafshejani; Bahman Khosravi; Shahin Soltani; Iraj Pakzad; Mahdi Mohammadian; Hamid Salehiniya; Zohre Momenimovahed
Journal:  Ann Transl Med       Date:  2016-01

2.  Effect of genetic ancestry to the risk of susceptibility to gastric cancer in a mixed population of the Brazilian Amazon.

Authors:  Ellen Moreno da Silva; Marianne Rodrigues Fernandes; Darlen Cardoso de Carvalho; Luciana Pereira Colares Leitao; Giovanna Chaves Cavalcante; Esdras Edgar Batista Pereira; Antônio André Conde Modesto; João Farias Guerreiro; Paulo Pimentel de Assumpção; Sidney Emanuel Batista Dos Santos; Ney Pereira Carneiro Dos Santos
Journal:  BMC Res Notes       Date:  2017-11-29

3.  The prevalence and expression pattern of melanoma-associated antigen 1 in esophageal squamous cell carcinoma: a historical cohort study.

Authors:  Kazem Anvari; Azar Fani Pakdel; Bahram Memar; Roya Parsamanesh; Seyyed Mojtaba Ejlalzadeh; Seyed Alireza Javadinia
Journal:  Electron Physician       Date:  2017-02-25

4.  Clinical significance of serum cathepsin B and cystatin C levels and their ratio in the prognosis of patients with esophageal cancer.

Authors:  Yan Yan; Kun Zhou; Liping Wang; Feng Wang; Xinfeng Chen; Qingxia Fan
Journal:  Onco Targets Ther       Date:  2017-04-03       Impact factor: 4.147

Review 5.  Bladder Cancer in Iran: An Epidemiological Review.

Authors:  Khadijeh Kalan Farmanfarma; Neda Mahdavifar; Hamid Salehiniya
Journal:  Res Rep Urol       Date:  2020-03-05

Review 6.  Epidemiologic Study of Gastric Cancer in Iran: A Systematic Review.

Authors:  Khadijeh Kalan Farmanfarma; Neda Mahdavifar; Soheil Hassanipour; Hamid Salehiniya
Journal:  Clin Exp Gastroenterol       Date:  2020-11-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.